Chitosan silk-based three-dimensional scaffolds containing gentamicin-encapsulated calcium alginate beads for drug administration and blood compatibility
Restricted accessResearch articleFirst published online April, 2015
Chitosan silk-based three-dimensional scaffolds containing gentamicin-encapsulated calcium alginate beads for drug administration and blood compatibility
In the present study gentamicin was encapsulated within calcium alginate beads and incorporated into porous chitosan, gelatin, double-hybrid silk fibroin, chitosan/gelatin and double-hybrid silk fibroin/chitosan scaffolds. Physiochemical, morphological and biological properties of fabricated amenable model systems were evaluated, revealing hemocompatible nature of double-hybrid silk fibroin/chitosan and double-hybrid silk fibroin scaffolds of hemolysis %<5 and porosity >85%. Fourier transform infrared results confirmed the blend formation and scanning electron microscope images showed good interconnectivity. Double-hybrid silk fibroin/chitosan-blended scaffold shows higher compressive strength and compressive modulus than other fabricated scaffolds. A comparative drug release profile of fabricated scaffolds revealed that double-hybrid silk fibroin/chitosan scaffold is a pertinent model system because of its prolonged drug release, optimal hemocompatability and high compressive modulus.
ShiXWangYJRenL. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications. Int J Pharm2009; 373: 85–92.
5.
SakanoSHasegawaYMurataY. Inhibitory effect of bFGF on endochondral heterotopic ossification. Biochem Biophys Res Commun2002; 293: 680–685.
6.
KumarSDuttaJDuttaPK. Preparation and characterization of N-heterocyclic chitosan derivatives based gels for biomedical applications. Int J Biol Macromol2009; 45: 330–337.
7.
ASTM Standard F756. Standard practice for assessment of hemolytic properties of materials, West Conshohocken, PA: ASTM International, 2008.
8.
CaoHKuboyamaN. A biodegradable porous composite scaffold of PGA/ß TCP for bone tissue engineering. Bone2010; 46: 386–395.
9.
LaiHLAbulkhalilACraigDQ. The preparation and characterization of drug loaded alginate and chitosan sponges. Int J Pharm2003; 251: 175–181.
10.
KumarSKohJTiwariDK. Optical study of chitosan-ofloxacin complex for biomedical applications. J Macromol Sci Part A2011; 48: 789–795.
11.
Alves da SilvaMLCrawfordAMundyJM. Chitosan/polyester-based scaffolds for cartilage tissue engineering: assessment of extracellular matrix formation. Acta Biomaterialia2010; 6: 1149–1157.
12.
LuGYKongLJShengBY. Degradation of covalently cross-linked carboxymethyl chitosan and its potential application for peripheral nerve regeneration. Eur Polym J2007; 43: 3807–3818.
13.
MeinelLHofmannSKarageorgiouV. The inflammatory responses to silk films in vitro and in vivo. Biomaterials2005; 26: 147–155.
14.
MandalBBKunduSC. Non-bioengineered silk fibroin protein 3D scaffolds for potential biotechnological and tissue engineering applications. Macromol Biosci2008; 8: 807–818.
15.
SheZZhangBJinC. Preparation and in vitro degradation of porous three-dimensional silk fibroin/chitosan scaffold. Polym Degrad Stab2008; 93: 1316–1322.
16.
MehtaASSinghBKDuttaPK. Electrospun chitin, chitosan and silk fibroin nanofibrous scaffolds: an emerging trend in biomedical applications. Asian Chitin J2014; 10: 25–28.
17.
MandalBBKunduSC. Calcium alginate beads embedded in silk fibroin as 3D dual drug releasing scaffolds. Biomaterials2009; 30: 5170–5177.
18.
Hima BinduTVLVidyavathiMKavithaK. Preparation and evaluation of ciprofloxacin loaded chitosan-gelatin composite films for wound healing activity. Int J Drug Delivery2010; 2: 173–182.
19.
KanangatSPostlethwaiteAHastyK. Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infections. Arthritis Res Therap2006; 8: 1–14.
20.
RockwoodDNPredaRCYücelT. Materials fabrication from Bombyx mori silk fibroin. Nature Protocol2011; 6: 1612–1631.
21.
BhardwajNKunduSC. Silk fibroin protein and chitosan polyelectrolyte complex porous scaffolds for tissue engineering applications. Carbohydr Polym2011; 85: 325–333.
22.
MaoJSZhaoLGYinYJ. Structure and properties of bilayer chitosan-gelatin scaffolds. Biomaterials2002; 24: 1067–1074.
23.
TighRSKarakeceiliAGumusdereliogluM. In vitro characterization of chitosan scaffolds: influence of composition and deacetylation degree. J Mater Sci Mater Med2007; 18: 1665–1674.
24.
CuiYLiuYCuiY. The nanocomposite scaffold of poly (lactide-co-glycolide) and hydroxyapatite surface-grafted with l-lactic acid oligomer for bone repair. Acta Biomaterialia2009; 5: 2680–2692.
25.
BłasińskaASzoslandL. Accumulation of drugs in dibutyryl chitin porous fibres. Polish Chitin Society2006; Monograph XI: 145–151.
26.
ArchanaDDuttaJDuttaPK. Evaluation of chitosan nanodressing for wound healing: Characterization, in vitro and in vivo studies. Int J Biol Macromol2013; 57: 193–203.
DuttaPKTripathiSMehrotraGK. Perspectives for chitosan based antimicrobial films in food applications. Food Chem2009; 114: 1173–1182.
29.
SmithPO'MearaENcNultyD. Influence of disc content on zone sizes obtained in standard disc diffusion antimicrobial susceptibility tests. Aquaculture2006; 261: 799–803.
30.
KumarSKumariMDuttaPK. Chitosan biopolymer schiff base: Preparation, characterization, optical and antibacterial activity. J Polym Mater Polym Biomater2014; 63: 173–177.
31.
RahmanMMPervezSNesaB. Preparation and characterization of porous scaffold composite films by blending chitosan and gelatin solutions for skin tissue engineering. Polym Int2013; 62: 79–86.
32.
WoodruffMAHutmacherDW. The return of a forgotten polymer polycaprolactone in the 21st century. Prog Polym Sci2010; 35: 1217–1256.
33.
JinHHLeeCHLeeWK. In-situ formation of the hydroxyapatite/chitosan-alginate composite scaffolds. Mater Lett2008; 62: 1630–1633.
34.
ByrneDPLacroixDPlanellJA. Simulation of tissue differentiation in a scaffold as a function of porosity, Young’s modulus and dissolution rate: application of mechanobiological models in tissue engineering. Biomaterials2007; 28: 5544–5554.
35.
HiguchiT. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci1961; 50: 874–875.
36.
SiepmannJSiepmannF. Mathematical modeling of drug delivery. Int J Pharm2008; 364: 328–343.
37.
PeschkaRDennehyCSzokaFCJr. A simple in vitro model to study the release kinetics of liposome encapsulated material. J Contr Rel1998; 56: 41–51.
38.
TrappmannBChenCS. How cells sense extracellular matrix stiffness: a material’s perspective. Curr Opin Biotechnol2013; 24: 948–953.
39.
RaafatDVon BargenKHaasA. Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol2008; 74: 3764–3773.
